chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nose bleed; This is a spontaneous report from a contactable consumer. An 83-year-old (non pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), (Batch/Lot Number: EL9264), via an unspecified route of administration, in left arm on 29Jan2021at 12:00, as DOSE 1, SINGLE for covid-19 immunization (age at vaccination: 83-years-old). The patient's medical history included heart issues and liver disease. Patient did not report any allergies. The patient also received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), (Batch/Lot Number: EN6201), via an unspecified route of administration, in left arm on 25Feb2021, as DOSE 2, SIN-GLE for covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient took her own medicines within two weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. Post vaccination, nasal swab was done on 30Mar2021, and the result was negative. On 30Jan2021, at 02:30, after first dose patient experienced nosebleed. She stated that she had nosebleed after each shot. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Swelling under left arm pit. Presuming in the lymph nodes. I have had breast cancer on right side but they removed 4 lymph nodes on left side of breast
Pt has an allergy to peanuts.  Pt c/o itching in the mouth 15mins after vaccination.  BP 111/71, HR 84, RR 16, O2 sat 99% on RA.  Pt did not disclose reaction to first dose.  Pt given 25mg Benadryl PO.  Pt stable and released from the vaccination site.
The EE completed Pfizer vaccine on 1/12/21-  She was diagnosed with positive COVID on 4/18, symptomatic.  High risk community exposure- husband and daughter tested positive on 4/15.
Bells palsy on left-side of face. 2nd dose batch/lot #ER8729 did the same thing. Did not report.  Shot date 04/09/2021.
This spontaneous report as received from a pharmacist refers to a 19 year old (gender not reported) whose concurrent or historical conditions were not reported. On 19-MAR-2015 and on 17-APR-2015 the patient received the second and third dose of GARDASIL (Lot # reported as K014891 for the second and the third dose) respectively. The patient had not reported or demonstrated any adverse effects. Additional information has been requested.
Swollen lymph nodes under left arm and on left collarbone. It's been 2 1/2 months and they are still slightly swollen.
Patient presented for a flu shot. Shot administered on 10/20/15 at 10 am. That evening call into the following day her arm became red and warm to the touch. She was concerned it could be cellulitis as it was warm and red. She presented to walk in care and was prescribed cephalexin 500 4 x a day for 10 days.
11-11-11 - flu like symptoms. 11-12-11 = vomiting diarrhea. Deep muscle pain loss of muscle control. 11-13-11 = severe muscle spasms attack. 11-14-11 to present Meniere's.
Saturday morning woke up to muscle ache and poor temperature regulation (Hot then cold then hot then cold)  as day progressed had headache and fatigue - by end of day Saturday had swollen area at injection site (red, hard lump about 2.5" x 1") other symptoms resolved by Sunday morning.
Shot on 29MAR21. First lethargy began 31MAR21, followed by mild chills 01APR21. Over the weekend the symptoms waned and seemed to be subsiding. Wednesday of the following week, 07APR21 the chills became increasingly unpleasant especially at night requiring two extra blankets. Sharp pain radiating horizontally along the "hip-girdle" and up along the spine on the right side began that night. In the morning the top of my head was painfully sensitive to touch (like it is when I have the flu), I was slightly groggy and while the chills had subsided the hip & back pain remained. I went to work thinking I might be passing a kidney stone as the symptoms were similar in location & intensity as when I passed a stone in 2003. The chills became so severe I was wearing my jacket in my office and that's when I made an appointment at a local Urgent Care facility to see if they could perform an ultrasound for stones. When the scan proved negative, I had to assume I was experiencing side-effects from the vaccine. The symptoms diminished considerably by Sunday, so I returned to work Monday 12APR21 with no other issues.
Facial swelling and problems breathing; Facial swelling and problems breathing; Blood pressure jumped up; She also did have a rash, but it was not a bad rash; This is a spontaneous report from a contactable consumer (patient).   A 49-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (at the age of 49-year-old) as dose 1, single for covid-19 immunisation. Medical history included patient has low blood pressure and some other rash for other medications. Concomitant medication was not reported. Patient stated, on an unspecified date, she end up in the Emergency Room but it was not an anaphylactic reaction. She had face swelling and problems breathing. Also anytime she would get up, her blood pressure would jump up. She does not normally have high blood pressure, she has low blood pressure. When she would get up and walk around or go up stairs, it would go up. She also did have a rash, but it was not a bad rash. Patient did not wish to provide the name of the other medications that she had the rash to. The patient underwent lab tests and procedures which included blood pressure measurement resulting jumped up BP on an unspecified date. Outcome of the events was unknown at the time of reporting.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
1120: Patient complained of tachycardia and anxiety. Patient immediately assed by onsite NP and EMS. Vitals were taken. Pulse 137, BP 134/101, 02 99%. EKG showed Sinus Tach. Patient denied chest pain, SOB, or headache. She reported she was nervous and has history of anxiety. Patient given water.  1130: Second set of vitals were taken. BP 139/93, P 91, 02 99%. Patient reported feeling better  1145: Third set of vitals taken. BP 128/89, P 86, O2 99%. Patient went home with no medical complaints
After a few hours i couldnt feel parts of my tongue, the next day my tongue was  itching and a little seollen, the next day it had some spots and was itching still,  10 days later i still feel some parts of my tongue itching specially the tip of my tongue and some times my tongue gets this pale color
AFTER TAKING VACCINE AND WHILE SITTING IN WAITING AREA PATIENT BEGAN TO FEEL QUEEZY AND HEAD HEAVY FEELING. THE PATIENT WAS ACCOMPANIED BY OTHER FAMILY MEMBERS. VILAT SIGNS WERE TAKEN AT TWO DIFFERENT TIME OVER A PERIOD OF 30 MINUTES AND WERE NORMAL. PATIENT DID STATE THAT SHE TOOK BENADRYL BEFORE TAKING THE VACCINE. BECAUSE THE PATIENT WAS FEELING BETTER SHE DID NOT WANT TO BE TRANSPORTED TO THE HOSPITAL AND SIGNED AN RMA. WE ASKED FOR A PHONE CALL WHEN THEY ARRIVE HIME AND AT 12:04 AM WE RECEIVED A PHONE CALL THAT EVERYONE WAS HOME SAFELY AND SHE WAS FEEKING OK.
A pharmacy buyer reported that a pt received an injection of Pnu-Imune 23 and subsequently, developed "sore arms". The reporter indicated that 2 pts experienced this event; however, they are not presently identifiable. An additional report will be generated when identifying information is provided.
Severe chills, fever of 103, body aches, headache, fatigue,  sore arm.  Lasted for 48 hours
AT Approximately 15 MINUTES after the administration OF THE SECOND DOSE MODERNA VACCINE, PATIENT DEVELOPED A MINOR RASH ON RIGHT FOREARM, AND UPPER NECK AREA, WITH C/O PRURITUS IN HANDS AND FACIAL AREAS. PATIENT ALSO COMPLAINED OF MILD GENERALIZED HEADACHE.  Medication(s) given: Benadryl 50mg PO. Vitals: BP 123/72, P 82, T 98.2, R 16, pulse ox 99%.  Pt  Monitored closely for 60 minutes, provided with hydration. Benadryl 50mg PO.  patient verbalized that she felt better that the itching had diminished. Pt remained alert and orientedx3, Airway intact, breathing unlabored. Patient verbalized that the headache is mild at this time and will take a Tylenol at home. Pt is stable to go home and will take a taxi. Patient was accompanied by her son. Pt verbalized understanding of teaching if any further symptoms reoccur such as difficulty breathing, nausea and vomiting lightheadeness, weakness and confusion etc. to call emergency services immediately. Pt was in no distress at the time of discharge.
after a below freezing temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number abxb35aa, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd July 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 23rd July 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The Physician reported that the patient was administrated with Bexsero after a below freezing temperature Excursion,which led to incorrect storage of drug. No adverse event was reported. The reporter consented to follow up. This case was 1 of 29 linked cases,reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021164775:same reporter US-GLAXOSMITHKLINE-US2021164789:same reporter US-GLAXOSMITHKLINE-US2021164795:Same reporter. US-GLAXOSMITHKLINE-US2021164788:same reporter US-GLAXOSMITHKLINE-US2021164781:same reporter US-GLAXOSMITHKLINE-US2021164791:same reporter US-GLAXOSMITHKLINE-US2021164787:same reporter US-GLAXOSMITHKLINE-US2021164803:same reporter US-GLAXOSMITHKLINE-US2021164783:same reporter US-GLAXOSMITHKLINE-US2021164777:same reporter US-GLAXOSMITHKLINE-US2021164779:same reporter US-GLAXOSMITHKLINE-US2021164798:Same reporter. US-GLAXOSMITHKLINE-US2021164802:same reporter US-GLAXOSMITHKLINE-US2021164784:same reporter US-GLAXOSMITHKLINE-US2021164786:same reporter US-GLAXOSMITHKLINE-US2021164797:Same reporter. US-GLAXOSMITHKLINE-US2021164801:same reporter US-GLAXOSMITHKLINE-US2021164799:Same reporter. US-GLAXOSMITHKLINE-US2021164793:same reporter US-GLAXOSMITHKLINE-US2021164792:same reporter US-GLAXOSMITHKLINE-US2021164804:same reporter US-GLAXOSMITHKLINE-US2021164771:same reporter US-GLAXOSMITHKLINE-US2021164794:same reporter US-GLAXOSMITHKLINE-US2021164769:same reporter US-GLAXOSMITHKLINE-US2021164800:same reporter US-GLAXOSMITHKLINE-US2021164808:same reporter US-GLAXOSMITHKLINE-US2021164806:same reporter US-GLAXOSMITHKLINE-US2021164786:same reporter US-GLAXOSMITHKLINE-US2021164787:same reporter
Mom states pt developed a 2" x 3" reddened, swollen area approx 2-3" below immunization site 24 hours post immunization was given. Shot given 9/25/02. Redness/pain developed 9/26/02. States it is painful to L arm. Advised to apply ice/take ibuprofen if no improvement or worsen will call to go to prompt care.
chills, fever, congestion, ear pain, rhinorrhea, sore throat, cough, myalgias, adenopathy
Shots given 10/31/06.  On 11/6 patient developed few red spots. 11/7 body covered with hives big hives some with deep purple center. Patient was given Zyrtec and hives (urticaria) resolved in 3-4 days.
Joint pain; Fatigue; Inappropriate schedule of vaccine administered; This is a spontaneous report received from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 22Mar2021 (in appropriate schedule of vaccine administered) at 14:00 (at the age of 71-year-old), as a single dose for COVID-19 immunisation. The patients medical history included arthritis. The patients concomitant medications included paracetamol (TYLENOL), hydrochlorothiazide (MANUFACTURER UNKNOWN) and meloxicam (MANUFACTURER UNKNOWN) for arthritis, since unspecified dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 08Mar2021 at 14:00 (at the age of 71-year-old), as a single dose, for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient experienced joint pain and fatigue on 23Mar2021 at 13:00. No therapeutic measures were taken for the reported events. The clinical outcome of events joint pain and fatigue was resolving at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
2-3 days p/vax pt had pain in same rt arm-h/a; pain kept increasing & got blisters on hand; dx w/shingles 16FEB by MD; pt now has shingles vesicles from fingers to shoulder;
Red mark (after the first dose); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red mark (after the first dose)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (Red mark (after the first dose)). At the time of the report, ERYTHEMA (Red mark (after the first dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications are not provided. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-059938 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-059938:Case for second dose
Information has been received from a nurse referring to a 41 year old male patient with HIV infection history. The patient had allergies to AMBIEN, JUSTIVA (unspecified drug). The nurse believed, but was not certain, that the patient received at least one dose of M-M-R II in childhood. Nurse could not provide any details of vaccinations prior to July 2015. The patient had lab work completed once annually. After negative titer results from July 2015, the patient received the first dose of M-M-R II (lot#, dose and route were not provided) at an unspecified time in July 2015. The patient was taking unspecified medications for "HIV regimen". At an unspecified time in July 2015, the patient had titers drawn and showed low titers to MMR. The patient did not seek medical attention. No lab work was completed since titers drawn. No treatment was given for the event. The outcome of the event was unknown. The patient seen in the office on 28-AUG-2015 and received the second dose of M-M-R II (batch# J006136, lot# 0116AE, which had expired 24-MAY-2015) 0.5 ml subcutaneously (expired product administered). The patient was doing fine. Additional information has been requested.
Swelling in shoulder and arm, raised and inflamed tissue at injection site, discoloration of skin on and surrounding injection site, itching in and surrounding area of injection site, mild bruising and hardening of tissues surrounding injection site.
Fever began 07/29/2011, over 100.5 by temporal scanner.  Fever ongoing while rash developed 07/31/2011.  Rash is pink spots, slightly raised.  Began on forehead and back of neck then spread over body.
Red hot round 1? raised then within an hour 3? raised round and very hot to touch and tender.  Used hot and cold compress then doctors office said to take Benadryl.
vial was first punctured on 27-Jun-2022 1:50PM, vial stored post puncture in refrigerator, administration of vaccine on 28-Jun-2022 at 8: 30 am; administer a booster vaccine from a vial that was left over night  past 12 hours to a patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer a booster vaccine from a vial that was left over night  past 12 hours to a patient) and PRODUCT STORAGE ERROR (vial was first punctured on 27-Jun-2022 1:50PM, vial stored post puncture in refrigerator, administration of vaccine on 28-Jun-2022 at 8: 30 am) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049L21A) for COVID-19 prophylaxis.     Patient had no previous allergies. Patient had no acute and chronic illnesses at the time of vaccination. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.  The patient's past medical history included COVID-19.    On 28-Jun-2022 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2022 at 8:30 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administer a booster vaccine from a vial that was left over night  past 12 hours to a patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was first punctured on 27-Jun-2022 1:50PM, vial stored post puncture in refrigerator, administration of vaccine on 28-Jun-2022 at 8: 30 am). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer a booster vaccine from a vial that was left over night  past 12 hours to a patient) and PRODUCT STORAGE ERROR (vial was first punctured on 27-Jun-2022 1:50PM, vial stored post puncture in refrigerator, administration of vaccine on 28-Jun-2022 at 8: 30 am) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported.  The vial was initially stored in the refrigerator on 27-Jun-2022. The vial did not undergo any temperature excursions. It was reported that patient did not seek medical care. Patient had not experienced a similar event in the past.  No treatment drug was reported.   Reporter did not allow further contact
pain on her right arm and right leg/both her hands feel like painful.; both her hands feel like cramped; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on her right arm and right leg/both her hands feel like painful.) and MUSCLE SPASMS (both her hands feel like cramped) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced PAIN IN EXTREMITY (pain on her right arm and right leg/both her hands feel like painful.) and MUSCLE SPASMS (both her hands feel like cramped). At the time of the report, PAIN IN EXTREMITY (pain on her right arm and right leg/both her hands feel like painful.) and MUSCLE SPASMS (both her hands feel like cramped) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided by the patient No treatment was received by the patient
Pt states stiff neck radiating to bilateral shoulders beginning 24 hours after injection. This continues five days later. In addition pt reports chills and nasuea
migraines not a day has passed that I have not had one; Pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An adult patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), outcome "not recovered", described as "migraines not a day has passed that I have not had one"; PAIN (non-serious), outcome "not recovered".  Additional Information: Reporter said when the COVID shot come out, had gotten it. Since then patient have had migraines not a day has passed that he/she have not had one. Patient was unable to find a medication that will relieve the pain. Patient was interested for a "Dui an". No one here seems to know where to turn or what to give the patient to relieve the pain. Patient was hoping that someone there at Pfizer could take some time to reply back to patient with the names of medication he/she could use to become somewhat "Normal" again. Then he/she could take the letter and show it to the Drs. where patient was located and change things around.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
This spontaneous report as received from a physician via a company representative, refers to a female patient of unknown age. In January 2013 the patient was vaccinated with GARDASIL dose 1. Route of administration was not provided. Lot number 9725106. After the first dose of GARDASIL was administered, the patient developed shortness of breath and headache, which lasted 2 days post vaccination. Patient sought medical attention by contacting physician. This patient will not received the second or third dose of GARDASIL vaccine. Therapy was discontinued. The outcome of shortness of breath and headache was reported as recovered/resolved. Causality assessment was not provided. Additional information has been requested.
High Blood Pressure now am on medication and I have never had High blood pressure nor have I been on BP medication. I have been taking medication for 2 weeks and my BP has maintained high
I signed up  to get the Flu shot during a work sponsored Flu/Covid vaccination event.  I sat down to get the Flu shot and was given the Covid Vaccine by accident by the pharmacy employee.
Immediately after, I got the normal and expected side effects with sore muscles and joints and a headache and fatigue and those went on for 3 days, maybe 3-5 days. The other symptoms subsided but I kept reported I had a headache that took me all the way to next vaccine and the time that happened on the 6th or 7th day I had a lingering headache and had facial spasms on the left side in my lower left corner lip and cheek pulling downwards. I called in and asked about 2nd vaccine and they said to get the 2nd vaccine and I was about to get it and got COVID-19 on 10/28/2021 and took a home test and had several confirmed, and basically, I just never recovered. I still have a headache and facial spasms and I've just been living with the pain because I barely take any medicine and I've had to take Tylenol every single day and it relieves the headache, and the facial spasms are intermittent and sporadic and more bothersome. The headache is in the center of my head. I was just concerned of the lingering side effects, and I didn't expect them to last this long.